Cytochrome P450 and monoclonal antibodies

In vitro antioxidative potential of lactoferrin and black tea polyphenols and protective effects in vivo on carcinogen activation, DNA damage, proliferation, invasion, and angiogenesis during experimental oral carcinogenesis.

Oncology research·2008

Pretreatment with black tea polyphenols modulates xenobiotic-metabolizing enzymes in an experimental oral carcinogenesis model.

Oncology research·2008

CYP2C subfamily, primarily CYP2C9, catalyses the enantioselective demethylation of the endocrine disruptor pesticide methoxychlor in human liver microsomes: use of inhibitory monoclonal antibodies in P450 identification.

Xenobiotica; the fate of foreign compounds in biological systems·2004

Monoclonal antibodies specific and inhibitory to human cytochromes P450 2C8, 2C9, and 2C19.

Drug metabolism and disposition: the biological fate of chemicals·2001

Cytochromes P450 2A6, 2E1, and 3A and production of protein-aldehyde adducts in the liver of patients with alcoholic and non-alcoholic liver diseases.

Journal of hepatology·2000

An inhibitory monoclonal antibody to human cytochrome P450 that specifically binds and inhibits P4502C9II, an allelic variant of P4502C9 having a single amino acid change Arg144 Cys.

Xenobiotica; the fate of foreign compounds in biological systems·2000

Peptide hormone-based combinational pharmacotherapies for chronic metabolic diseases.

Pharmacological reviews·2026

Chronic pain in Alzheimer disease and the role of neuroimmune interactions.

Pharmacological reviews·2026

Renal aging and associated diseases: Common mechanisms and therapeutic approaches.

Pharmacological reviews·2026

Recent advances in methotrexate pharmacology and potential therapeutic uses in age-related cardiometabolic and neurodegenerative diseases.

Pharmacological reviews·2026

Exploration of multifunctional characteristics and regulatory mechanism of promoter G-quadruplexes.

Pharmacological reviews·2026

Aryl hydrocarbon receptor pharmacology-mechanisms, ligands, and therapeutic potential.

Pharmacological reviews·2026

Decoding the Microscopic Effects of Biocompatible Ionic Liquids on Model Phospholipid Membrane.

The journal of physical chemistry. B·2026

Distribution of amphetamine, benzoylecgonine, cocaethylene, cocaine, fentanyl, and methamphetamine in seven regions of the brain.

Journal of forensic sciences·2026

Synthetic Diastereomers of the Fungal Cycloheptapeptide Paraisariamide A Retain Ternatin-Like Biological Activity.

ACS medicinal chemistry letters·2026

Antioxidant Profiling of Glycosmis cyanocarpa: In Vitro Assays and Pearson's Correlation Study.

BioMed research international·2026

Natural rubber latex allergy: causes, symptoms, and modern diagnostic methods.

Postepy dermatologii i alergologii·2026

Integrated biomarker analysis of multi-organ effects following MDMA and alcohol co-consumption in Pakistan: A pilot study.

Toxicology reports·2026

Related Experiment Videos

Cytochrome P450 and monoclonal antibodies

Related Concept Videos

In vitro antioxidative potential of lactoferrin and black tea polyphenols and protective effects in vivo on carcinogen activation, DNA damage, proliferation, invasion, and angiogenesis during experimental oral carcinogenesis.

Pretreatment with black tea polyphenols modulates xenobiotic-metabolizing enzymes in an experimental oral carcinogenesis model.

CYP2C subfamily, primarily CYP2C9, catalyses the enantioselective demethylation of the endocrine disruptor pesticide methoxychlor in human liver microsomes: use of inhibitory monoclonal antibodies in P450 identification.

Monoclonal antibodies specific and inhibitory to human cytochromes P450 2C8, 2C9, and 2C19.

Cytochromes P450 2A6, 2E1, and 3A and production of protein-aldehyde adducts in the liver of patients with alcoholic and non-alcoholic liver diseases.

An inhibitory monoclonal antibody to human cytochrome P450 that specifically binds and inhibits P4502C9II, an allelic variant of P4502C9 having a single amino acid change Arg144 Cys.

Peptide hormone-based combinational pharmacotherapies for chronic metabolic diseases.

Chronic pain in Alzheimer disease and the role of neuroimmune interactions.

Renal aging and associated diseases: Common mechanisms and therapeutic approaches.

Recent advances in methotrexate pharmacology and potential therapeutic uses in age-related cardiometabolic and neurodegenerative diseases.

Exploration of multifunctional characteristics and regulatory mechanism of promoter G-quadruplexes.

Aryl hydrocarbon receptor pharmacology-mechanisms, ligands, and therapeutic potential.

Decoding the Microscopic Effects of Biocompatible Ionic Liquids on Model Phospholipid Membrane.

Distribution of amphetamine, benzoylecgonine, cocaethylene, cocaine, fentanyl, and methamphetamine in seven regions of the brain.

Synthetic Diastereomers of the Fungal Cycloheptapeptide Paraisariamide A Retain Ternatin-Like Biological Activity.

Antioxidant Profiling of Glycosmis cyanocarpa: In Vitro Assays and Pearson's Correlation Study.

Natural rubber latex allergy: causes, symptoms, and modern diagnostic methods.

Integrated biomarker analysis of multi-organ effects following MDMA and alcohol co-consumption in Pakistan: A pilot study.

Related Experiment Videos

Cytochrome P450 and monoclonal antibodies

Related Concept Videos

Related Articles